Strategic Innovation Fund

Last updated

The Strategic Innovation Fund (SIF) is the program of Innovation, Science and Economic Development Canada designed to support the "Canadian innovation ecosystem," [1] which includes providing "funding to innovative sectors" such as "advanced manufacturing, agri-food, clean technology, clean resources, digital industries, and health and biosciences." [2] [3] [4] The SIF covers all sectors of the Canadian economy and is available to both for-profit and not-for profit organizations. [1]

Contents

It supports those large-scale projects that help position Canada's interests in the global knowledge-based economy, promoting the long-term competitiveness of Canadian industries, clean growth, and the "advancement of Canada's strategic technological advantage." [1] With a single, streamlined fund, it provides businesses with access to a simpler application process, more timely processing, and responsive assistance. [5]

History

Funded in the March 2017 Canadian federal budget and slated to last only five years, the SIF was introduced by Prime Minister Justin Trudeau and his 29th Canadian Ministry in July 2017. [6] It was marketed as "A Simpler, More Flexible Tool to Grow Canada’s Economy," and accomplished this by "consolidat[ing] and simplify[ing] existing business innovation programming, in particular the Strategic Aerospace and Defence Initiative, Technology Demonstration Program, Automotive Innovation Fund and Automotive Supplier Innovation Program." [7]

Since the 2018 Canadian federal budget, the SIF now only provides funds in chunks of over $10 million. [8] In June that year, the SIF was the mechanism of support for the steel and aluminum industries of Canada when the Trump Administration placed customs duties on them. [8]

In October 2018, Canadian Minister of Innovation, Science and Economic Development, Navdeep Bains, announced that the SIF would invest C$49.3 million in General Fusion. [9] In December 2019, General Fusion raised $65 million in Series E equity financing from Singapore’s Temasek Holdings, Bezos Expeditions, and Chrysalix, concurrently with another $38 million from the SIF. The firm said that the funds would permit it to begin the design, construction, and operation of its Fusion Demonstration Plant. [10] [11]

On 20 March 2020, the Canadian government announced a plan to ramp up production of medical equipment, switching assembly lines to produce ventilators, masks, and other personal protective gear. Companies would be able to access funds through the SIF. Trudeau stated that Canadian medical supply firms Thornhill Medical, Medicom, and Spartan Bioscience were looking to expand production. To address shortages and supply-chain disruption, Canada passed emergency legislation that waived patent protection, giving government-selected companies or organizations the right to produce patented products without permission from the patent holder. [12] According to the Bains, "the country's entire industrial policy will be refocused to prioritize the fight against COVID-19." [13] [14]

Projects

Recent projects of SIF, as of September 2021, include: [4]

SIF projects by sector, as of August 2021 [15]
Name(s)Advanced manufacturing Agrifood "Resources of the future"Health & biosciences Clean technology Digital industries
AbCellera Biologics Inc.x
Abraham Innovation Systems Inc.xx
Advantech Satellite Networks (now Spacebridge)x
Aerospace Innovation and Research Network (AIR) – (Aerospace Industries Association of Canada)xx
AGS Automotive Systemsxx
Alcoa Lauralco Management Companyx
Algoma Steel Inc. xx
Algoma Tubes Inc. and Prudential Steel Ltd. (Tenaris)x
Aluminerie Alouette Inc. xxx
ArcelorMittal Canada Inc.xx
ArcelorMittal Dofasco G.P.xx
Arch Biopartners Inc.x
Attabotics Inc. xx
Bell Helicopter Textron Canada Ltd and partnersxxx
Bell Textron Canada xx
BioVectraxx
BlackBerry QNXx
Blue Solutions Canada Inc.xx
Bluedrop Performance Learning Inc. x
Burloak Technologiesxx
CAE Inc.xxx
Canada Kuwait Petrochemical Corp.xx
Canadian Agri-Food Automation and Intelligence Network (CAAIN)xx
Canadian Food Innovators Network (CFIN)xx
Carbon Engineering Ltd. xx
CBN Nano Technologies Inc. and Canadian Bank Note Company, Ltdx
Centre for Excellence in Mining Innovation xx
Clean Resource Innovation Networkxx
Cognitive Systems Corp.x
Coulson Aircrane Ltd.x
Creative Destruction Labx
Digital Health and Discovery Platform (DHDP) - Terry Fox Research Institute / Imagiaxx
D-Wave Systems Inc. x
Domtar Inc. xx
Edesa Biotech Research, Inc.x
Elysis Limited Partnershipxx
EVRAZ xx
exactEarth x
General Fusion xx
Gerdau Ameristeel Corporation xx
Heico Canada Holding Companyx
High Q xx
Immune Biosolutions Inc.x
Industry Consortium for Image Guided Therapy (ICIGT) - Sunnybrook Research Institute xx
Innovation ENCQORx
Inter Pipeline xxx
ISARACorporationx
JP Bowman Ltd.xx
KABS Laboratories Inc.x
Kruger Inc. xxx
Lakeside Plastics Ltd.xx
Linamar Corporation xx
LNG Canada Development Inc. xxx
Maple Leaf Foods Inc. xx
Marwood Metal Fabrication Ltd.xx
Mastercard Technologies Canada ULCx
Medicago Inc. x
Meltech Innovation Canada Inc.x
Meridian Lightweight Technologies Inc.xx
MindBridge Analytics Inc.x
Moltex Energy Canada Inc.x
Natural Products Canadaxx
Nokia x
Northstarxx
NOVA Chemicals xxx
Nova Steel Inc.xxx
Nova Tube Inc.x
Novocol Pharmaceutical of Canadax
Origin Materials Canada Holding Ltd.x
Pratt & Whitney Canada xx
Precision NanoSystems Inc.x
Ranovusxxx
Redline Communications Inc. x
Resilience Biotechnologies Inc.x
Rockport Networks Inc.xx
Sanofi Pasteur Limited x
Sciemetric Instruments Inc.xx
Siemens Canada xxxx
Stelco Inc. x
STEMCELL Technologies x
SWITCH Materials Inc.xx
Synergx Technologies Inc.xx
Svante Inc.x
Tekna Plasma Systemsxx
Telesat Canada x
Terrestrial Energy Inc. xx
The Lion Electric Co. xx
Toyota Motor Manufacturing Canada xx
Variation Biotechnologies Inc. x
Volvo Group Canada Inc.xx
Woodbridge Foam Corporationx
3M Canada Companyx

Primary sector of company in bold ("x")

Medical Countermeasures projects

In the wake of the COVID-19 pandemic, the SIF was designated by the Canadian government in March 2020 to deliver the Medical Countermeasures (MCM) initiative and was given authority to invest $792 million to fund clinical trials and manufacturing capacity at scale. The MCM funding stream is divided into three types of projects: vaccines, therapies, and biomanufacturing projects.

Announced MCM projects [16]
Project nameProvinceSIF contribution (CAD)Total project cost (CAD)Announcement dateType
Abcellera Biologics Inc.BC$175,631,000$287,353,0002020-05-03Therapeutics and biomanufacturing
Variation Biotechnologies Inc. (VBI)ON$55,976,000$74,636,0002020-08-05Vaccines
Precision NanoSystems Inc.BC$18,203,000$24,271,0002020-10-23Vaccines
Medicago Inc. QC$173,000,000$428,002,0002020-10-23Vaccines and biomanufacturing
Arch BioPartners ON$6,715,000$8,953,0002020-12-15Therapeutics
Edesa Biotech Research, Inc.ON$14,053,000$18,738,0002021-02-02Therapeutics
Precision NanoSystems Inc.BC$25,112,000$50,224,0002021-02-02Biomanufacturing
KABS Laboratories Inc.QC$54,209,000$84,843,0002021-03-16Biomanufacturing
Novocol Pharmaceutical of Canada ON$32,716,000$72,632,0002021-03-16Biomanufacturing
Immune Biosolutions Inc.QC$13,442,000$18,670,0002021-03-16Therapeutics
Resilience Biotechnologies Inc.ON$199,159,000$401,518,0002021-05-18Biomanufacturing
Total$768,216,000$1,469,840,000

Related Research Articles

<span class="mw-page-title-main">National Research Council Canada</span> Canadian national research organization

The National Research Council Canada is the primary national agency of the Government of Canada dedicated to science and technology research and development. It is the largest federal research and development organization in Canada.

<span class="mw-page-title-main">Minister of Innovation, Science and Industry</span> Canadian minister

The minister of innovation, science, and industry is the minister of the Crown in the Canadian Cabinet who is responsible for overseeing the economic development and corporate affairs department of the government of Canada; Innovation, Science and Economic Development Canada.

<span class="mw-page-title-main">Navdeep Bains</span> Canadian politician (born 1977)

Navdeep Singh Bains is a Canadian politician who served as Minister of Innovation, Science and Industry from 2015 to 2021. A member of the Liberal Party, he represented the riding of Mississauga—Malton in the House of Commons from 2015 to 2021. He previously represented the riding of Mississauga—Brampton South from 2004 to 2011.

In Canada, the Regional Development Agencies (RDA) are the seven federal government agencies responsible for addressing key economic challenges and furthering economic development, diversification, and job creation specific to their respective regions.

Innovation, Science and Economic Development Canada is a department of the Government of Canada. ISED is responsible for a number of the federal government's functions in regulating industry and commerce, promoting science and innovation, and supporting economic development. The department was known as Industry Canada (IC) prior to 2015.

The Social Sciences and Humanities Research Council of Canada, often colloquially pronounced 'shirk', is a Canadian federal research-funding agency that promotes and supports post-secondary research and training in the humanities and social sciences. It is one of three major federal granting agencies that together are referred to as the "Tri-Council" or "Tri-Agency.

Housing, Infrastructure and Communities Canada (HICC) is a department of the Government of Canada responsible for the federal public infrastructure policy. Construction and development of infrastructure is primarily the responsibility of provincial/territorial and municipal governments, as such, much of the department's work involves co-financing projects with other levels of government.

<span class="mw-page-title-main">Canadian Institutes of Health Research</span> Canadian federal agency

The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.

The Canada Foundation for Innovation is an independent corporation created by the Government of Canada to invest in research facilities and equipment in Canada's universities, colleges, research hospitals, and non-profit research institutions.

<span class="mw-page-title-main">Biomedical Advanced Research and Development Authority</span> Government organization in Washington D.C., United States

The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.

General Fusion is a Canadian company based in Richmond, British Columbia, which is developing a fusion power technology based on magnetized target fusion (MTF). The company was founded in 2002 by Dr. Michel Laberge. The company has more than 150 employees.

The Utah Science Technology and Research Initiative (USTAR) is a technology-based economic development agency funded by the state of Utah. The organization works to develop ideas and research into marketable products and successful companies through its competitive grant and entrepreneur support programs. USTAR facilitates the diversification of the state’s tech economy, increases private follow-on investment, and supports the creation of technology-based start-up firms, higher-paying jobs and additional business activity leading to a statewide expansion of Utah’s tax base.

<span class="mw-page-title-main">Automotive industry in Canada</span> Overview of the automotive industry in Canada

The automotive industry in Canada consists primarily of assembly plants of foreign automakers, most with headquarters in the United States or Japan, along with hundreds of manufacturers of automotive parts and systems, a sector represented by the APMA.

<span class="mw-page-title-main">Canada–Cuba relations</span> Bilateral relations

Canada and Cuba have established diplomatic relations with one another since 1945, following their centuries-old informal trading relationship. Informal trade relations were established between the colonies of Atlantic Canada and the Captaincy General of Cuba during the 18th century. The informal trade relationship continued into the 20th century until formal diplomatic relations was finally established.

Biosecurity in the United States is governed by the Bureau of Western Hemisphere Affairs, which is part of the US Department of State. It obtains guidance and advice on specific matters relating to biosecurity from various other government agencies.

<span class="mw-page-title-main">Coalition for Epidemic Preparedness Innovations</span> Public-private organization for vaccine development

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

Women and Gender Equality Canada, known as Status of Women Canada from 1976 to 2018, is a department of the Government of Canada. Previously an agency under the Department of Canadian Heritage, it gained department status after a vote in December 2018 passed the Budget Implementation Act, 2018, No. 2, which included legislation in favour of evolving the agency into a department and increasing its power, duties, and functions to those concerning not just women, but all gender identities. The purpose of the department is to "advance equality with respect to sex, sexual orientation, and gender identity or expression through the inclusion of people of all genders, including women, in Canada's economic, social, and political life" as well as the intersection of these with other identities such as ethnicity, age, socio-economic level, disability, and others. The department partners with other areas of government, both federal and provincial, as well as civil and private organizations in order to achieve this. It is currently headed by the Minister for Women and Gender Equality, Marci Ien.

<span class="mw-page-title-main">COVID-19 pandemic in Canada</span>

The COVID-19 pandemic in Canada is part of the ongoing worldwide pandemic of coronavirus disease 2019. It is caused by severe acute respiratory syndrome coronavirus 2. Most cases over the course of the pandemic have been in Ontario, Quebec, British Columbia and Alberta. Confirmed cases have been reported in all of Canada's provinces and territories.

<span class="mw-page-title-main">Federal aid during the COVID-19 pandemic in Canada</span> National economic response to the COVID-19 pandemic

The Government of Canada introduced multiple temporary social security and financial aid programs in response to the economic impacts of the COVID-19 pandemic in Canada. The initial CA$82-billion aid package was announced on March 18, 2020 by Justin Trudeau.

<span class="mw-page-title-main">PTX-COVID19-B</span> Vaccine candidate against SARS-CoV-2 (COVID-19)

PTX-COVID19-B is a messenger RNA (mRNA)-based COVID-19 vaccine, a vaccine for the prevention of the COVID-19 disease caused by an infection of the SARS-CoV-2 coronavirus, created by Providence Therapeutics—a private Canadian drug company co-founded by Calgary, Alberta-based businessman Brad T. Sorenson and San Francisco–based Eric Marcusson in 2013. A team of eighteen working out of Sunnybrook Research Institute in Toronto, Ontario developed PTX-COVID19-B in less than four weeks, according to the Calgary Herald. Human trials with sixty volunteers began on January 26, 2021, in Toronto.

References

  1. 1 2 3 Government of Canada. "About the program". www.ic.gc.ca. Retrieved 2021-09-25.
  2. "STRATEGIC INNOVATION FUND - Stream 1-3". OECD O.N.E Sight. 4 November 2019.
  3. Kviselius, Niklas Z (May 2020). "Public Research and Innovation Funding Actors in Canada" (PDF). Stiftelsen för internationalisering av högre utbildning och forskning.
  4. 1 2 "Strategic Innovation Fund". Government of Canada. 2021-06-10.
  5. "Chapter 1 – Skills, Innovation and Middle Class Jobs". Government of Canada. 2017-03-22.
  6. Anderson, Paul (15 August 2017). "Strategic Innovation Fund: Putting Canada on the Global Innovation Lab". RDP Associates Inc.
  7. "Chapter 1 – Skills, Innovation and Middle Class Jobs". Government of Canada. 2017-03-22.
  8. 1 2 "Strategic Innovation Fund". Government of Canada. Innovation, Science and Economic Development Canada. 2018-08-24.
  9. Boyle, Alan (26 October 2018). "Canadian government invests $38M in General Fusion to boost energy research". Geekwire. Retrieved 19 November 2018.
  10. "General Fusion Closes $65M of Series E Financing". Global Newswire. Retrieved 16 December 2019.
  11. "Bezos-Backed Fusion Startup Raises $100 Million for Demo System". Financial Post. Retrieved 16 December 2019.
  12. "Exclusive: Canada gets Biomerieux formula for free to produce virus testing chemicals". Reuters. April 23, 2020. Archived from the original on April 27, 2020. Retrieved May 1, 2020.
  13. "Ottawa unveils plan to harness industry to ramp up production of COVID-19 medical gear &#124". CBC News. Archived from the original on March 21, 2020. Retrieved March 20, 2020.
  14. Platt, Brian (March 20, 2020). "COVID-19: Trudeau announces plan to 'mobilize industry' to produce medical supplies". National Post. Archived from the original on March 23, 2020. Retrieved March 20, 2020.
  15. Government of Canada, Innovation. "Overview of announced projects". www.ic.gc.ca. Retrieved 2021-09-26.
  16. Government of Canada, Innovation. "COVID-19 related vaccines, therapies and biomanufacturing projects". www.ic.gc.ca. Retrieved 2021-09-25.